[APPLICATION OF DIFERELIN AND ITS PERSPECTIVES]

Area of Science:

• Oncology
• Endocrinology

Background:

• Prostate cancer treatment often involves hormonal therapies.
• Luteinizing hormone-releasing hormone (LHRH) analogs are a key class of these therapies.

Purpose of the Study:

• To provide an overview of LHRH analog use in prostate cancer.
• To present clinical experience with Diferelin, an LHRH analog.
• To describe abiraterone treatment for hormone-resistant prostate cancer.

Main Methods:

• Literature review of LHRH analogs in prostate cancer.
• Clinical case experience with Diferelin.
• Review of abiraterone efficacy in hormonal resistance.

Main Results:

• LHRH analogs represent an established treatment modality.
• Diferelin offers a specific example of LHRH analog application.
• Abiraterone shows utility in managing advanced, hormone-resistant disease.

Conclusions:

• LHRH analogs are integral to prostate cancer management.
• Abiraterone provides an option for treatment-refractory patients.